Analyst consensus rating
BioStem Technologies Analyst Rating: none
Direct answer
BioStem Technologies's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.00.
Forecast evidence checked October 28, 2026.
Get free BioStem Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.48
- Average price target
- $7.00
- High price target
- $7.00
- Low price target
- $7.00
- Low target gap
- +373%
- Target upside
- +373%
- High target gap
- +373%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- October 28, 2026
- Valid through
- November 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BioStem Technologies?
BioStem Technologies has a verified none consensus. The same dataset has an average price target of $7.00.
How far are BioStem Technologies's low and high targets from the recorded price?
The low target implies +373%, while the high target implies +373%.
How many analysts are included in BioStem Technologies's consensus?
The verified consensus includes 1 analysts.
How is BioStem Technologies's target upside or downside calculated?
The average target of $7.00 is divided by the recorded price of $1.48, then one is subtracted to produce +373%. This does not guarantee a future return.
When was BioStem Technologies's analyst forecast verified?
The data was verified on 2026-10-28. The dataset is valid through 2026-11-04.